Search Results

1-11 of 11 results for subject:"Wellcome Foundation"

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, if he will list the members of the Committee on Safety of Medicines who have, in each year from 1987 to date, declared outside interests in (a) SmithKline Beecham, (b) SmithKline and French laboratories, (c) Merck Sharpe and Dohme, (d) Pasteur Merieux...

Asked by

Norman Baker (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

29 February 2000

For answer on

7 March 2000

Answered on

7 March 2000

Mr. Baker: To ask the Secretary of State for Health if he will list the members of the Committee on Safety of Medicines who have, in each year from 1987 to date, declared outside interests in (a) SmithKline Beecham, (b) SmithKline and French laboratories, (c) Merck Sharpe and Dohme, (d) Pasteur Merieux and (e) the Wellcome Foundation. [112835] Ms Stuart: This information is published annually in the "Medicines Act 1968 Advisory Bodies--Annual Reports" copies of which, dating back to 1987, are available in the Library, The reports include lists of interests in the pharmaceutical industry declared by each committee member. The 1999 report, which is due to be published in July this year, will include the entries in the table relating to members of the Committee on Safety of Medicines (CSM) (this information is correct as at 6 March 2000). In addition, Professor J. H. Scarffe is Head of Programmes (Career Development) at the Wellcome Trust. _________________________________________________________________________________________________. CMS member Name of company Nature of interest Professor J. Chipman SmithKline Beecham Non-personal--research grants Professor J. Darbyshire SmithKline Beecham Non-personal--support for clinical trials Professor H. Dargie SmithKline Beecham Personal--consultancy and non-personal--clinical trial Dr. M. Donaghy SmithKline Beecham Personal--shareholder Dr. B. Evans SmithKline Beecham Personal--fees and shares Professor E. Gordon-Smith Pasteur-Merieux Non-personal--research grants Professor M. Langman Merck Sharpe and Dohme Non-personal--support/research collaborations Dr. A. MacGowan SmithKline Beecham Personal--consultancy and non-personal--fellowship Professor B. Park SmithKline Beecham Non-personal--lectureship Professor J. F. Smyth SmithKline Beecham Personal--occasional meetings and non-personal--clinical trials support Professor I. Weller SmithKline Beecham Non-personal--trials and study Professor K. Woodhouse SmithKline Beecham Non-personal--clinical research trials Merck Sharpe and Dohme Non-personal--clinical research trials _________________________________________________________________________________________________.

Date

7 March 2000

Reference

112835; 345 c630W

House

House of Commons

Dept of Trade and Industry

Answered by

Jonathan Evans (Conservative)

Answering body

Department of Trade and Industry

Type

Oral answers to questions

Date

8 February 1995

Reference

254 c331

House

House of Commons

Dept of Trade and Industry

Supplementary on takeover of Wellcome by Glaxo.

Asked by

Lord Moonie (Labour)

Answering body

Department of Trade and Industry

Oral questions - 1st Supplementary

Status

Answered

Date

8 February 1995

Reference

254 c331

House

House of Commons

Dept of Trade and Industry

What consideration he has given to the long term effect on research and development of the proposed takeover of Wellcome by Glaxo.

Asked by

John Battle (Labour)

Answering body

Department of Trade and Industry

Type

Written questions

Status

Answered

Date

30 January 1995

Reference

253 c477W

House

House of Commons

Dept of Health

What support she will give to litigants against the Wellcome group in respect of claims for damage caused by Septrin.

Asked by

Martin Redmond (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

27 January 1995

Reference

253 c392W

House

House of Commons

Patent protection for biotechnological inventions. European Communities Select Committee (HL) Fourth report, with proceedings and evidence (HL 28-i to ii not printed separately).

Type

Select Committee reports; House of Lords papers; Parliamentary committees

Committee

European Communities Committee

Notes

Received 17.03.94

Date

1 March 1994

Reference

HL 28 1993/94

House

House of Lords

Regulation of the United Kingdom biotechnology industry & global competitiveness. Science & Technology Select Committee (HL) seventh report in 2 volumes with evidence (previously HL 80-i to xii) and appendices. (Part 2 of 2).

Type

Select Committee reports; House of Lords papers; Parliamentary committees

Committee

Science and Technology Committee (HL)

Notes

DEBATE;LH 2 DEC 1993

Date

13 July 1993

Reference

HL 80 1992/93

House

House of Lords

Dept of Health

If she will list all the meetings which took place from 1985 to 1988 between representatives of the Wellcome Foundation and her Department or with Ministers. - Inc figure & fact that it is possible to quantify these only at disproportionate cost.

Asked by

George Galloway (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 May 1993

Reference

224 c563W

House

House of Commons

Dept of Health

How many (a) civil servants within her Department, (b) consultants sitting upon any of the advisory committees since 1977 or (c) other individuals involved organisationally in the Concorde trials have received money in royalties or grants, or had career positions, or directorships or consultancies, with the Wellcome Foundation, the Wellcome...

Asked by

George Galloway (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

12 May 1993

Reference

224 c479-80W

House

House of Commons

Dept of Health

If she will review the complaint made in 1992 by the film company Meditel to the Medicines Control Agency, relating to advertising claims by the Wellcome Foundation in relation to AZT; & what action was taken by the MCA & DH in respect of the complaint made by Meditel in...

Asked by

George Galloway (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

11 May 1993

Reference

224 c386W

House

House of Commons

Untitled Written question

To give all funds or grants made available to NHS laboratories, hospitals or consultants for purpose of conducting research on HIV infection or AIDS by following organisations: the Wellcome Foundation, Burroughs Wellcome, Abbot Laboratories, du Pont and Glaxo, identifying organisation, amount, principal recipient & purpose of grant.

Asked by

Ann Clwyd (Labour)

Answering body

Department of Health and Social Security

Type

Written questions

Status

Answered

Date

21 June 1988

Reference

135 c539-40W;135 c535-6W

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher